Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing news in brief

June 22, 2010
Manufacturing and Production Almac, CPL Biologicals, KV Pharma, KV Pharmaceutical, NerPharMa, ProBioGen

German contract manufacturer ProBioGen is bought by Egypt’s Minapharm, plus there are facility updates from NerPharMa DS, CPL Biologicals and …

News
NDA_Panos

NDA appoints Dr Panos Tsintis

June 22, 2010
Sales and Marketing NDA, appointment, sales and marketing

European regulatory affairs consulting group NDA has appointed Dr Panos Tsintis medical advisor to NDA Regulatory Science in a move …

Appointment

Dr Geoffrey Nichol joins Ikaria

June 22, 2010
Research and Development Ikaria, appointment, research and development

US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …

Appointment

Working Life: Jo Ferdinando

June 22, 2010
Manufacturing and Production, Research and Development Shire, Working Life, careers

How did you find your way into your most current role? After completing a BSc in Microbiology and Virology at …

Feature
Andrew Witty

Let’s avoid further stand-offs, says Witty

June 22, 2010
Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …

News
Blog footer

Digital Pharma: Online trial safety reporting

June 21, 2010
Research and Development FDA, MHRA, digital research, drug safety

From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …

News
GW laboratory

Bayer launches world’s first cannabis-derived prescription drug

June 21, 2010
Sales and Marketing Bayer, GW Pharmaceuticals, Sativex

Bayer Healthcare has launched the world’s first cannabis-derived prescription drug in the UK. Sativex treats the spasticity symptoms of multiple …

News

GSK tops access to medicines ranking

June 21, 2010
Sales and Marketing GlaxoSmithKline, developing world, medicines access

GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …

News

Tasigna more effective than Glivec, says Novartis

June 21, 2010
Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …

News

Depomed pulls diabetes drug Glumetza

June 21, 2010
Manufacturing and Production Depomed, Glumetza, manufacturing compliance

Another pharmaceutical manufacturer has been forced to recall products because of contamination caused by a chemical used to treat wooden …

News

AMRI buys Hyaluron to enter prefilled syringes market

June 21, 2010
Manufacturing and Production AMRI, Hyaluron

Contract manufacturing organisation Albany Molecular Research Inc (AMRI) has added to its capabilities with the $27 million purchase of US …

News
Ecteinascidia turbinata

NICE rejects Yondelis in ovarian cancer

June 21, 2010
Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer

New cancer treatment Yondelis has been rejected by NICE in a preliminary ruling on its use in relapsed ovarian cancer. …

News

Avastin will remain gold standard for lung cancer to 2018

June 20, 2010
Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin

 Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …

News
NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010
Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …

News

Fishawack acquires Alpha-Plus

June 18, 2010
Medical Communications fishawack

Fishawack has acquired fellow medical communications agency Alpha-Plus as it continues its ‘buy and build’ expansion plan. This has recently …

News

Contract research news in brief

June 18, 2010
Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …

News

Prolia gets early thumbs up from NICE

June 18, 2010
Sales and Marketing Amgen, NICE, Prolia

Amgen’s new treatment to prevent bone fractures caused by osteoporosis has been given preliminary approval from the UK’s cost effectiveness …

News

J&J expands recall of ‘musty’ products

June 18, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance

Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …

News

MedImmune Ventures appoints Ron Laufer

June 18, 2010
Research and Development AstraZeneca, MedImmune, appointment, research and development

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …

Appointment

Bayer signs cancer stem cell research deal

June 18, 2010
Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026